Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 136.19M | 116.39M | 101.63M | 85.22M | 75.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 136.19M | 116.39M | 101.63M | 85.22M | 75.01M |
| Cost of Revenue | 65.14M | 55.92M | 49.81M | 43.34M | 37.93M |
| Gross Profit | 71.05M | 60.47M | 51.83M | 41.88M | 37.09M |
| SG&A Expenses | 131.77M | 121.49M | 113.36M | 100.57M | 88.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 245.36M | 221.04M | 202.78M | 178.62M | 155.74M |
| Operating Income | -109.17M | -104.65M | -101.15M | -93.40M | -80.72M |
| Income Before Tax | -105.90M | -106.56M | -104.55M | -98.45M | -87.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -105.90 | -106.56 | -104.55 | -98.45 | -87.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.90M | -106.56M | -104.55M | -98.45M | -87.15M |
| EBIT | -109.17M | -104.65M | -101.15M | -93.40M | -80.72M |
| EBITDA | -105.36M | -101.50M | -98.35M | -90.52M | -77.88M |
| EPS Basic | -2.25 | -2.33 | -2.33 | -2.20 | -1.96 |
| Normalized Basic EPS | -1.40 | -1.41 | -1.41 | -1.33 | -1.18 |
| EPS Diluted | -2.25 | -2.33 | -2.33 | -2.20 | -1.96 |
| Normalized Diluted EPS | -1.40 | -1.41 | -1.41 | -1.33 | -1.18 |
| Average Basic Shares Outstanding | 189.13M | 183.31M | 179.64M | 178.80M | 177.59M |
| Average Diluted Shares Outstanding | 189.13M | 183.31M | 179.64M | 178.80M | 177.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |